Literature DB >> 1533851

Low levels of coagulation inhibitors in patients with Clostridium difficile infection.

B Aronsson1, M Blombäck, S Eriksson, N Egberg.   

Abstract

To investigate levels of coagulation inhibitors in sera from patients with Clostridium difficile-associated diarrhoea and colitis, commercially available antigen assays were used for immunochemical determination of antithrombin III, protein C and free protein S. Sera from patients with Clostridium difficile-associated diarrhoea and colitis showed significantly lowered levels of all measured inhibitors as compared to controls (Student's t test). Protein C (mean +/- SD): 0.70 +/- 0.30 vs. 1.28 +/- 0.23, t = 6.61, p less than 0.001; antithrombin: 0.70 +/- 0.21 vs. 0.90 +/- 0.17, t = 3.12, p less than 0.01; free protein S: 0.27 +/- 0.06 vs. 0.37 +/- 0.08, t = 3.7, p less than 0.001. Infection with C. difficile may lead to loss of coagulation inhibitors and constitutes a risk for thromboembolic complications.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1533851     DOI: 10.1007/bf01711063

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  11 in total

1.  Medical implications of nosocomial infection with Clostridium difficile.

Authors:  S Eriksson; B Aronsson
Journal:  Scand J Infect Dis       Date:  1989

2.  Nosocomial acquisition of Clostridium difficile infection.

Authors:  L V McFarland; M E Mulligan; R Y Kwok; W E Stamm
Journal:  N Engl J Med       Date:  1989-01-26       Impact factor: 91.245

3.  Hypoalbuminemia, ascites, and pseudomembranous colitis after clindamycin therapy.

Authors:  R A Pastore; R G Kadair
Journal:  South Med J       Date:  1974-07       Impact factor: 0.954

Review 4.  Clostridium difficile: clinical considerations.

Authors:  J G Bartlett
Journal:  Rev Infect Dis       Date:  1990 Jan-Feb

Review 5.  Incidence of thromboembolism in association with congenital disorders in coagulation and fibrinolysis.

Authors:  J Conard; M H Horellou; M Samama
Journal:  Acta Chir Scand Suppl       Date:  1988

Review 6.  Pseudomembranous colitis: pathogenesis and therapy.

Authors:  F J Tedesco
Journal:  Med Clin North Am       Date:  1982-05       Impact factor: 5.456

7.  Protein-losing enteropathy associated with Clostridium difficile infection.

Authors:  A H Rybolt; R G Bennett; B E Laughon; D R Thomas; W B Greenough; J G Bartlett
Journal:  Lancet       Date:  1989-06-17       Impact factor: 79.321

8.  Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980-1982.

Authors:  B Aronsson; R Möllby; C E Nord
Journal:  J Infect Dis       Date:  1985-03       Impact factor: 5.226

9.  Enzyme-linked immunosorbent assay (ELISA) for antibodies to Clostridium difficile toxins in patients with pseudomembranous colitis and antibiotic-associated diarrhoea.

Authors:  B Aronsson; M Granström; R Möllby; C E Nord
Journal:  J Immunol Methods       Date:  1983-06-10       Impact factor: 2.303

10.  Acquired antithrombin III deficiency and thrombosis in the nephrotic syndrome.

Authors:  R H Kauffmann; J J Veltkamp; N H Van Tilburg; L A Van Es
Journal:  Am J Med       Date:  1978-10       Impact factor: 4.965

View more
  1 in total

Review 1.  Clostridium difficile Induced Inflammasome Activation and Coagulation Derangements.

Authors:  Marta Mattana; Riccardo Tomasello; Claudia Cammarata; Paola Di Carlo; Teresa Fasciana; Giulio Giordano; Alessandro Lucchesi; Sergio Siragusa; Mariasanta Napolitano
Journal:  Microorganisms       Date:  2022-08-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.